| Literature DB >> 31652506 |
Vivien Reynaud1,2, Daniela Muti3,4, Bruno Pereira5, Annick Greil6, Denis Caillaud7, Ruddy Richard8,9,10, Emmanuel Coudeyre11,12, Frédéric Costes13,14.
Abstract
Risk of a fall is increased in individuals with chronic obstructive pulmonary disease (COPD), and is usually evaluated using the Berg Balance Scale (BBS), but this is difficult to perform in everyday clinical practice. We aimed to prospectively predict short-term fall recurrence in COPD patients using a predetermined cut-off value of the Timed Up and Go test (TUG). In stable COPD patients, we collected self-reported records of the number of falls in the previous year, and measured TUG and BBS scores for each individual. Records of fall recurrence were obtained prospectively at 6-months after the initial evaluation. Among the 50 patients recruited, 23 (46%) had at least one fall during the past year. The optimal diagnosis value for the TUG to detect a fall was 10.9 s with a sensitivity of 100% and a specificity of 97%. A cut-off of 11 s predicted fall recurrence with high sensitivity and specificity (93% and 74%, respectively). The TUG as well as the BBS score detected fallers, and a cut-off value of 11 s predicted fall recurrence. TUG could be easily incorporated into the scheduled functional evaluations of COPD patients, could predict the risk of a fall and when appropriate, could guide specific balance training exercises to prevent fall.Entities:
Keywords: Chronic obstructive pulmonary disease; Fall; Hypoxia; Postural balance; Risk factor; Timed Up and Go test
Year: 2019 PMID: 31652506 PMCID: PMC6832491 DOI: 10.3390/jcm8101752
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Characteristics of study participants and pulmonary function test results in faller and non-faller groups, grouped according to long-term oxygen therapy (LTOT) treatment.
| All | LTOT− | LTOT+ | Effect of LTOT | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Fallers | Non-Fallers |
| Fallers | Non-Fallers |
| In Fallers | In Non-Fallers | ||
|
| 50 | 6 | 19 | 17 | 8 | ||||
|
| 66.2 ± 8.2 | 65.0 ± 4.1 | 64.2 ± 7.3 | 68.6 ± 9.8 | 66.4 ± 8.8 | ||||
|
| 28.0 ± 6.5 | 24.2 ± 3.8 | 26.0 ± 5.5 | 32.0 ± 7.4 | 27.0 ± 3.7 | 0.004 | |||
|
| 51.8 ± 15.9 | 63.3 ± 20.4 | 51.4 ± 15.4 | 50.0 ± 15.4 | 47.6 ± 13.2 | ||||
|
| 87.1 ± 20.7 | 88.3 ± 21.1 | 83.1 ± 19.8 | 82.6 ± 15.4 | 105.4 ± 25.2 | 0.04 | 0.04 | ||
|
| 123.0 ± 21.7 | 113.7 ± 31.7 | 122.2 ± 18.8 | 118.4 ± 18.0 | 141.8 ± 19.8 | 0.01 | 0.03 | ||
|
| 55.3 ± 11.6 | 54.1 ± 8.7 | 54.1 ± 13.1 | 57.2 ± 12.0 | 55.2 ± 9.6 | ||||
|
| 45.5 ± 18.3 | 38.6 ± 7.5 | 57.5 ± 19.7 | 0.01 | 37.6 ± 13.0 | 33.7 ± 15.9 | |||
|
| 79.0 ± 24.2 | 71.1 ± 15.8 | 93.8 ± 12.1 | 0.02 | 59.6 ± 26.4 | 91.0 ± 14.8 | 0.001 | 0.03 | |
|
| 116.5 ± 37.9 | 98.1 ± 23.5 | 134.4 ± 42.3 | 0.02 | 95.0 ± 26.3 | 133.4± 29.6 | 0.008 | ||
|
| 2 (4%) | 0 | 0 | 2 (11.7%) | 0 | ||||
Data are given as means ± SD; when significant, p values are given between groups for the effects of fall and of LTOT). BMI: body mass index; FEV1: Forced Expiratory Volume in 1 s; FVC: Forced Expiratory Volume; TLC: Total Lung Capacity; RV: Residual Volume; DLCO: diffusing capacity for carbon monoxide; 6MWD: 6-min walking distance; qPT: quadriceps peak torque; pred: predicted value.
Body composition measured by biphotonic absorptiometry in fallers and non-fallers grouped according to long-term oxygen therapy treatment.
| All | LTOT− | LTOT+ | Effect of LTOT | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Fallers | Non-Fallers |
| Fallers | Non-Fallers |
| In Fallers | In Non-Fallers | ||
|
| 27.8 ± 7.9 | 28.9 ± 6.2 | 23.7 ± 8.0 | 32.5 ± 6.8 | 26.9 ± 6.5 | ||||
|
| 53.1 ± 11.7 | 44.8 ± 9.8 | 52.8 ± 12.7 | 56.6 ± 9.9 | 52.5 ± 12.6 | 0.03 | |||
|
| 68.8 ± 8.4 | 68.4 ± 5.8 | 71.6 ± 10.3 | 65.0 ± 6.5 | 70.2 ± 6.2 | ||||
|
| 20.0 ± 3.4 | 17.3 ± 3.2 | 19.8 ± 3.1 | 0.04 | 21.3 ± 19.7 | 19.7 ± 3.6 | 0.007 | ||
|
| 7.7 ± 1.5 | 6.7 ± 0.9 | 7.7 ± 1.3 | 8.1 ± 1.5 | 7.8 ± 1.7 | 0.04 | 0.02 | ||
Data are mean ± SD. LTOT−, patients not treated with long-term oxygen therapy; LTOT+, patients treated with long-term oxygen therapy; FM, fat mass; FFM, fat-free mass; FFMI, fat-free mass index; SMI, skeletal mass index.
Agreement between Berg Balance Scale and Timed Up and Go test to detect the risk of fall.
| All | LTOT− | LTOT+ | |
|---|---|---|---|
|
| |||
|
| 0.92 | 0.87 | 0.92 |
|
| 95.0 (75.1–99.9) | 80.0 (28.4–99.5) | 100 (78.2–100) |
|
| 96.7 (82.8–99.9) | 100 (83.0–100) | 90.0 (55.5–99.7) |
|
| 95.0 (75.1–99.9) | 100 (39.8–100) | 93.8 (69.8–99.8) |
|
| 96.7 (82.8–99.9) | 95.2 (76.2–99.9) | 100 (66.4–100) |
|
| |||
|
| 0.96 | 1.00 | 0.92 |
|
| 100 (83.2; 100) | 100 (47.8; 100) | 90.0 (55.5–99.7) |
|
| 96.7 (82.8; 99.9) | 100 (83.2; 100) | 93.8 (69.8–99.8) |
|
| 95.2 (76.2; 99.9) | 100 (47.8; 100) | 100 (66.4–100) |
|
| 100 (88.1; 100) | 100 (83.2; 100) | 90.0 (55.5–99.7) |
Data are given as means and 95% confidence intervals. LTOT−, patients not treated with long-term oxygen therapy; LTOT+, patients treated with long-term oxygen therapy; PPV, positive predictive value; NPV, negative predictive value.
Figure 1Receiver operating characteristic (ROC) curves for detecting fallers with the Berg Balance Scale score (BBS, black) and with the Timed Up and Go test (TUG, red). Area under curves (AUC) is indicated at the bottom of the paragraph.
Figure 2Forest plot of the multivariable analysis of determinants of past falls. The analysis was adjusted for gender, age, and BMI, all of which were non-significant determinants, and which were therefore omitted from the graph for clarity. LTOT, treatment with long-term oxygen therapy; FFM, fat-free mass (kg); 6MWD%pred, 6-min walking distance expressed as a percentage of the predicted value; qPT 60°, isokinetic quadriceps peak torque (PT) at concentric 60°.